1. Home
  2. RLAY vs EVLV Comparison

RLAY vs EVLV Comparison

Compare RLAY & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.82

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.30

Market Cap

988.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
EVLV
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
988.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
EVLV
Price
$7.82
$6.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$16.00
$9.13
AVG Volume (30 Days)
2.3M
3.2M
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,355,000.00
$136,501,000.00
Revenue This Year
$27.30
$31.08
Revenue Next Year
$7.43
$17.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.16
52 Week Low
$1.78
$2.64
52 Week High
$8.36
$8.91

Technical Indicators

Market Signals
Indicator
RLAY
EVLV
Relative Strength Index (RSI) 64.31 40.38
Support Level $6.28 $5.49
Resistance Level $8.36 $6.24
Average True Range (ATR) 0.50 0.34
MACD 0.14 0.02
Stochastic Oscillator 76.56 41.60

Price Performance

Historical Comparison
RLAY
EVLV

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: